News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
734,055 Results
Type
Article (43077)
Company Profile (268)
Press Release (690693)
Multimedia
Podcasts (97)
Webinars (20)
Section
Business (205346)
Career Advice (2073)
Deals (35654)
Drug Delivery (130)
Drug Development (81786)
Employer Resources (174)
FDA (16605)
Job Trends (15026)
News (347835)
Policy (32927)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2639)
Accelerated approval (46)
Adcomms (26)
Allergies (170)
Alliances (49724)
ALS (214)
Alzheimer's disease (1790)
Antibody-drug conjugate (ADC) (443)
Approvals (16974)
Artificial intelligence (656)
Autoimmune disease (281)
Automation (54)
Bankruptcy (362)
Best Places to Work (11665)
BIOSECURE Act (21)
Biosimilars (220)
Biotechnology (176)
Bladder cancer (187)
Brain cancer (71)
Breast cancer (744)
Cancer (5778)
Cardiovascular disease (469)
Career advice (1760)
Career pathing (41)
CAR-T (328)
CDC (59)
Celiac Disease (3)
Cell therapy (886)
Cervical cancer (47)
Clinical research (70915)
Collaboration (2046)
Company closure (5)
Compensation (1380)
Complete response letters (80)
COVID-19 (2756)
CRISPR (108)
C-suite (1110)
Cystic fibrosis (151)
Data (7760)
Decentralized trials (3)
Denatured (30)
Depression (159)
Dermatology (83)
Diabetes (584)
Diagnostics (6932)
Digital health (54)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (316)
Drug pricing (203)
Drug shortages (31)
Duchenne muscular dystrophy (282)
Earnings (92010)
Editorial (67)
Employer branding (21)
Employer resources (153)
Events (119729)
Executive appointments (1076)
FDA (20299)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (34)
Funding (1709)
Gene editing (234)
Generative AI (56)
Gene therapy (720)
GLP-1 (1052)
Government (4762)
Grass and pollen (6)
Guidances (408)
Healthcare (19056)
HIV (79)
Huntington's disease (58)
IgA nephropathy (97)
Immunology and inflammation (286)
Immuno-oncology (92)
Indications (188)
Infectious disease (3095)
Inflammatory bowel disease (216)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (288)
Interviews (329)
IPO (16685)
IRA (50)
Job creations (3665)
Job search strategy (1459)
JPM (59)
Kidney cancer (19)
Labor market (98)
Layoffs (569)
Leadership (38)
Legal (7991)
Liver cancer (99)
Longevity (32)
Lung cancer (761)
Lymphoma (427)
Machine learning (60)
Management (59)
Manufacturing (1035)
MASH (184)
Medical device (13977)
Medtech (14095)
Mergers & acquisitions (20212)
Metabolic disorders (1489)
mRNA (205)
Multiple sclerosis (187)
NASH (17)
Neurodegenerative disease (414)
Neuropsychiatric disorders (105)
Neuroscience (3295)
Neurotech (1)
NextGen: Class of 2026 (6558)
Non-profit (4565)
Now hiring (77)
Obesity (699)
Opinion (293)
Ovarian cancer (218)
Pain (250)
Pancreatic cancer (294)
Parkinson's disease (359)
Partnered (33)
Patents (592)
Patient recruitment (667)
Peanut (62)
People (59703)
Pharmaceutical (60)
Pharmacy benefit managers (33)
Phase 1 (22108)
Phase 2 (31232)
Phase 3 (23257)
Pipeline (8460)
Policy (316)
Postmarket research (2578)
Preclinical (9447)
Press Release (65)
Prostate cancer (293)
Psychedelics (54)
Radiopharmaceuticals (320)
Rare diseases (1071)
Real estate (5998)
Recruiting (71)
Regulatory (25485)
Reports (56)
Research institute (2438)
Resumes & cover letters (361)
Rett syndrome (38)
RNA editing (21)
RSV (89)
Schizophrenia (176)
Series A (287)
Series B (211)
Service/supplier (11)
Sickle cell disease (111)
Special edition (25)
Spinal muscular atrophy (165)
Sponsored (48)
Startups (3657)
State (2)
Stomach cancer (18)
Supply chain (127)
Tariffs (89)
The Weekly (65)
Vaccines (1092)
Venture capital (108)
Weight loss (449)
Women's health (124)
Worklife (20)
Date
Today (211)
Last 7 days (933)
Last 30 days (3419)
Last 365 days (30295)
2026 (11928)
2025 (30218)
2024 (35284)
2023 (40138)
2022 (51269)
2021 (55836)
2020 (54231)
2019 (46720)
2018 (35183)
2017 (32286)
2016 (31724)
2015 (37788)
2014 (31550)
2013 (26644)
2012 (28872)
2011 (29546)
2010 (27562)
Location
Africa (751)
Alabama (91)
Alaska (7)
Arizona (348)
Arkansas (14)
Asia (39921)
Australia (6550)
California (13135)
Canada (3725)
China (1331)
Colorado (562)
Connecticut (573)
Delaware (400)
Europe (86585)
Florida (1962)
Georgia (421)
Hawaii (3)
Idaho (62)
Illinois (1045)
India (88)
Indiana (596)
Iowa (23)
Japan (530)
Kansas (130)
Kentucky (50)
Louisiana (40)
Maine (75)
Maryland (1577)
Massachusetts (9381)
Michigan (358)
Minnesota (707)
Mississippi (6)
Missouri (143)
Montana (33)
Nebraska (29)
Nevada (140)
New Hampshire (84)
New Jersey (3455)
New Mexico (29)
New York (3432)
North Carolina (1664)
North Dakota (9)
Northern California (6576)
Ohio (393)
Oklahoma (23)
Oregon (41)
Pennsylvania (2638)
Puerto Rico (29)
Rhode Island (50)
South America (1124)
South Carolina (85)
South Dakota (2)
Southern California (5175)
Tennessee (209)
Texas (2084)
United States (46342)
Utah (393)
Vermont (1)
Virginia (316)
Washington D.C. (80)
Washington State (1051)
West Virginia (4)
Wisconsin (124)
Wyoming (2)
734,055 Results for "berkeley lights inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Light-Activated Ruvidar and Interferon Demonstrate Enhanced Efficacy
Theralase(R) Demonstrates Additive Anti-Cancer Effect in Bladder Cancer In-Vitro Model when Light-Activated Ruvidar(R) is Combined with Interferon
March 2, 2026
·
6 min read
Press Releases
Fermeate Raises $2M Seed to Improve Fermentation with Light
April 29, 2026
·
2 min read
Press Releases
Illumisoft Lighting Corp. Provides Corporate Update Following Commencement of Trading
May 5, 2026
·
14 min read
Manufacturing
Innovent’s CDMO gets green light to make biologics at large Chinese plant
The license, which Innovent’s Altruist business said is the first of its kind, positions the CDMO to support commercial clients as it works to expand the plant’s capacity to 172,000 liters.
April 9, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026
April 8, 2026
·
4 min read
Press Releases
Nextleaf Advances Capex-Light Model with New Micro-Processing Site Licence, Supporting Revenue Growth and Margin Expansion
April 20, 2026
·
6 min read
Immunology and inflammation
AAD 2026: Sanofi, Incyte, Roivant and Alumis Make Headway Into Skin Diseases
Presentations at the 2026 meeting of the American Academy of Dermatology not only demonstrate the therapeutic potential of next-generation skin drugs but also shed light on how they might fare on the market.
March 31, 2026
·
4 min read
·
Tristan Manalac
Editorial
Prasad’s Request To Remain Anonymous Shines Light on FDA’s Transparency Problem
While requests by government officials for anonymity when speaking to the media are nothing new, the practice attracts more scrutiny when the Department for Health and Human Services has pledged a commitment to “radical transparency.”
March 13, 2026
·
7 min read
·
Heather McKenzie
AbCellera Announces that the U.S. Patent Trial and Appeal Board Has Denied Berkeley Lights’ Request for Rehearing
AbCellera (Nasdaq: ABCL) announced that the United States Patent and Trademark Office’s (USPTO) Patent Trial and Appeal Board (PTAB) has denied a rehearing request in an Inter Partes Review (IPR) filed by Berkeley Lights, Inc. (Berkeley Lights) that challenged AbCellera’s U.S. Patent No. 10,087,408 (the ‘408 Patent).
July 24, 2023
·
4 min read
Press Releases
Brain Cancer Canada Marks Brain Cancer Awareness Month in May with National Landmark Lightings, Community Events, New Research Investments, and a Call to Action
April 21, 2026
·
4 min read
1 of 73,406
Next
